Abstract
Introduction
The recent Institute of Medicine report From Cancer Patient to Cancer Survivor: Lost in Transition recommended that ‘survivorship care plans’ be created for patients as they complete primary therapy for cancer in order to ensure clarity for all involved about patients’ diagnoses, treatment received, and plan for surveillance. It should explicitly identify the providers responsible for each aspect of ongoing care, and provide information on resources available for psychosocial and other practical issues that may arise as a result of the prior cancer diagnosis. The IOM stated that survivorship care plans ‘have strong face validity and can reasonably be assumed to improve care unless and until evidence accumulates to the contrary.’
Materials and methods
As an example of how to approach evaluation of a new health care delivery service, this article reviews the health services research agenda that will have to be carried out in order to refine and determine the clinical utility of survivorship care planning.
Results
For any change in medical practice such as this to really occur, not only is advocacy needed from a number of different stakeholders, but there must also be convincing, scientifically sound evidence that the change is cost effective, improves outcomes of interest, and is feasible.
Conclusion
It is incumbent on the research community to rigorously evaluate each element of survivorship care plans in order to justify their widespread adoption. Similar approaches can be taken to evaluate other health care delivery questions.
Similar content being viewed by others
References
Cooper, R. A., Getzen, T. E., McKee, H. J., Laud, P., et al. (2002). Economic and demographic trends signal an impending physician shortage. Health Affairs(Millwood), 21, 140–154.
Fong, Y., Cohen, A. M., Fortner, J. G., Enker, W. E., Tumbull, A. D., Coit, D. G., et al. (1997). Liver resection for colorectal metastases. Journal of Clinical Oncology, 15, 938–946.
Ganz, P. A. (2005). A teachable moment for oncologists: Cancer survivors, 10 million strong and growing! Journal of Clinical Oncology, 23, 5458–5460.
Johnson, F. E. (1997). Overview. In F. E. Johnson & K. S. Virgo (Eds.), Cancer Patient Follow-up (p. 4). St. Louis: Mosby.
Miedema, B., MacDonald, I., & Tatemichi, S. (2003). Cancer follow-up care. Patients’ perspectives. Canadian Family Physician, 49, 890–895.
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., et al. (2006). Chronic health conditions in adult survivors of childhood cancer. New England Journal of Medicine, 355, 1572–1582.
Pfannschmidt, J., Hoffmann, H., Muley, T., Krysa., S., Trainer, C., Dienemann, H., et al. (2002). Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Annals of Thoracic Surgery, 74, 1653–1657.
Pfannschmidt, J., Klode, J., Muley, T., Krysa, S., Trainer, C., Dienemann, H., et al. (2006). Pulmonary metastasectomy in patients with soft tissue sarcomas: Experiences in 50 patients. Thoracic and Cardiovascular Surgeon, 54, 489–492.
Author information
Authors and Affiliations
Corresponding author
Additional information
An earlier form of this article served as a background paper for the ‘Implementing Survivorship Care Planning’ Workshop, an Institute of Medicine National Cancer Policy Forum in collaboration with the National Coalition for Cancer Survivorship, Lance Armstrong Foundation, and National Cancer Institute, May 15 and 16, 2006, The National Academies Keck Center, 500 Fifth Street, NW, Washington DC
Rights and permissions
About this article
Cite this article
Earle, C.C. Long term care planning for cancer survivors: a health services research agenda. J Cancer Surviv 1, 64–74 (2007). https://doi.org/10.1007/s11764-006-0003-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-006-0003-9